REACH Compliance for Chemicals

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• REACH compliance requires identifying your role as manufacturer, importer, or downstream user, then determining if your substance volume triggers registration duties under EU law.
• The practical first step is compiling substance identity data, tonnage information, and intended uses before preparing a technical dossier and chemical safety report.
• REACH applies to the European Union market, so US-based operations need registration only when they export substances or mixtures into EU countries.

Understanding REACH and Its Scope

REACH stands for Registration, Evaluation, Authorisation and Restriction of Chemicals. It is a European Union regulation that governs the production and use of chemical substances. The regulation places responsibility on industry to demonstrate that chemicals placed on the EU market are safe for human health and the environment.

The regulation applies to substances manufactured or imported into the EU in quantities of one tonne or more per year. This includes substances on their own, in mixtures, or in certain articles where intentional release is intended. Companies based outside the EU are not directly subject to REACH, but their EU-based importer or an appointed only representative must fulfill registration obligations.

For a newcomer to chemical regulatory affairs, the central concept is that REACH shifts the burden of proof from public authorities to industry. Instead of regulators proving a substance is dangerous, companies must generate data and demonstrate safe use. This principle shapes every step of the compliance process.

At a Glance: REACH Compliance Overview

Core Principles of REACH

Registration as the Foundation

Registration is the first and most substantial obligation under REACH. A manufacturer or importer must register each substance at or above the one tonne per year threshold. The registration dossier must include information about the substance identity, its properties, how it is manufactured or used, and the associated risks.

The amount of data required increases with tonnage. Substances at higher tonnage bands require more extensive testing and a chemical safety report. The chemical safety report documents the hazards of a substance and the measures needed to control risks during manufacture and use.

Evaluation by Authorities

After registration, the European Chemicals Agency and member state competent authorities evaluate submissions. Dossier evaluation checks whether registrations comply with information requirements. Substance evaluation investigates concerns about specific substances that may pose risks to health or the environment.

Evaluation can lead to requests for additional information from registrants. Companies must respond within specified deadlines or risk having their registration rejected. This step demonstrates why accurate and complete initial submissions matter for smooth compliance.

Authorisation for Substances of Very High Concern

Certain substances are identified as substances of very high concern because they are carcinogenic, mutagenic, toxic to reproduction, persistent, bioaccumulative, or have equivalent levels of concern. These substances are placed on the candidate list and may eventually be included in Annex XIV, which triggers the authorisation requirement.

Companies wishing to use an Annex XIV substance must apply for authorisation. The application must demonstrate that risks are adequately controlled or that socioeconomic benefits outweigh the risks. Authorisation is granted for specific uses and time-limited periods, after which companies must seek renewal.

Restrictions on Manufacturing and Use

Restrictions are the safety net of REACH. A restriction can limit or ban the manufacture, placing on the market, or use of a substance when it poses an unacceptable risk. Restrictions apply across the EU and can affect entire supply chains.

Companies must check whether their substances are subject to restrictions in Annex XVII. Compliance requires ensuring that products meet any concentration limits or other conditions specified in the restriction entry.

Practical Workflow for REACH Compliance

Step 1: Determine Your Role and Obligations

The first decision is identifying whether your organization is a manufacturer, importer, downstream user, or only representative. A manufacturer produces a substance within the EU. An importer brings a substance into the EU customs territory. A downstream user uses a substance in industrial or professional activities. An only representative is a legal entity established in the EU that represents a non-EU manufacturer.

Your role determines which obligations apply. Manufacturers and importers have registration duties. Downstream users generally rely on the registrations of their suppliers but must comply with risk management measures and may need to communicate up the supply chain.

Step 2: Compile Substance Identity and Tonnage Data

Accurate substance identification is the foundation of a compliant dossier. You need the chemical name, CAS number, molecular structure, and composition. For substances with multiple constituents or impurities, you must describe the full composition.

Tonnage data determines your information requirements. Calculate the total annual tonnage of the substance manufactured or imported. This calculation includes all quantities, even if the substance is used in different products or by different customers.

Step 3: Gather Existing Hazard Data

Before commissioning new studies, search available data sources for existing information on your substance. Public databases, scientific literature, and industry consortia may contain relevant studies. REACH encourages data sharing to avoid unnecessary animal testing.

If data gaps remain, you may need to conduct new studies. The testing strategy must follow the information requirements in the REACH annexes, which specify which endpoints to address at each tonnage band.

Step 4: Prepare the Technical Dossier

The technical dossier is the core submission document. It contains the substance identity, manufacturing process information, classification and labelling, guidance on safe use, and study summaries or robust study summaries for all required endpoints.

The dossier is submitted through the IUCLID format, which is the software application used for chemical data management. The European Chemicals Agency provides guidance on how to complete each section of the dossier.

Step 5: Develop the Chemical Safety Report

For substances at or above 10 tonnes per year, a chemical safety report is required. This document includes the hazard assessment, exposure assessment, and risk characterisation for all identified uses.

The chemical safety report must cover the full life cycle of the substance, from manufacture through use to disposal. It must also describe the risk management measures that control exposure and the operational conditions under which the substance is used safely.

Step 6: Submit and Pay Fees

Registration dossiers are submitted through the REACH-IT portal. Fees apply based on company size and tonnage band. Small and medium-sized enterprises receive reduced fees, but must provide supporting documentation to claim this status.

After submission, the European Chemicals Agency performs a completeness check. If the dossier is incomplete, the agency issues a request for more information. The registration number is granted only after the completeness check passes.

Step 7: Maintain Compliance Through Updates

Registration is not a one-time event. You must update your dossier when new information becomes available, when tonnage increases, or when the substance classification changes. Updates must be submitted without undue delay.

Annual tonnage reporting is also required for certain substances. This reporting helps authorities track actual volumes and verify that registrations remain appropriate.

Roles and Career Pathways in Regulatory Affairs

Regulatory Affairs Scientist

A regulatory affairs scientist in the chemical sector manages submissions, prepares dossiers, and communicates with regulatory agencies. The role requires understanding both scientific data and legal requirements. Scientists in this field interpret study results and translate them into regulatory language.

The U.S. Bureau of Labor Statistics describes related occupations in the life, physical, and social science fields, noting that these roles typically require a bachelor's degree or higher for entry-level positions. Graduate degrees are common for advanced regulatory roles.

Regulatory Affairs Specialist

Regulatory affairs specialists focus on the procedural aspects of compliance. They track regulatory changes, prepare documentation, and coordinate submissions across product portfolios. This role requires attention to detail and strong organizational skills.

The U.S. Department of Labor's O*NET OnLine database lists regulatory affairs specialists under the broader category of compliance officers, noting that these positions involve reviewing documents for compliance and advising management on regulatory matters.

Toxicologist and Risk Assessor

Toxicologists contribute to REACH compliance by designing and interpreting toxicity studies. They assess the hazards of substances and determine safe exposure levels. Risk assessors combine hazard data with exposure information to characterise risk.

These roles require advanced scientific training. The National Institutes of Health Office of Intramural Training and Education describes research career development pathways that include postdoctoral training and ongoing professional development for scientists in biomedical and related fields.

Data Manager and IT Specialist

REACH compliance depends on managing large volumes of chemical data. Data managers maintain substance databases, ensure data quality, and support dossier preparation. IT specialists develop and maintain the systems used for regulatory submissions.

The National Science Foundation careers page describes technical and administrative roles within a scientific organization, illustrating how data management and information technology support research and regulatory functions.

Career Development and Certification

Regulatory affairs is a specialized field that rewards continuous learning. Professional certification programs are available through industry organizations, though specific credentials vary by jurisdiction and employer expectations.

The American Society for Microbiology careers page emphasizes the importance of networking and professional development for scientists seeking to advance their careers. Building a professional network through conferences and industry associations can open doors to regulatory roles.

For those interested in animal-related regulatory work, the Association of American Veterinary Medical Colleges describes career paths in veterinary medicine, which can include roles in pharmaceutical regulation and animal health product compliance.

Records and Measurements for Compliance

Tonnage Tracking

Accurate tonnage records are the starting point for REACH compliance. Maintain a system that tracks annual manufactured or imported quantities for each substance. This system should capture data by calendar year and by substance identity.

Review tonnage data regularly to identify when a substance crosses a tonnage threshold. Crossing a threshold triggers new information requirements and potentially a chemical safety report obligation.

Study Data Management

Keep detailed records of all studies conducted or referenced in your dossier. Each study record should include the study design, results, and conclusions. Robust study summaries must provide enough detail for authorities to assess the study without accessing the full report.

Store raw data and study reports in a secure system that allows retrieval for dossier updates or regulatory inquiries. Data retention should follow your organization's document management policies.

Supply Chain Communication

REACH requires communication up and down the supply chain. Safety data sheets must accompany substances and mixtures that meet classification criteria. Exposure scenarios must be communicated to downstream users when a chemical safety report is required.

Maintain records of safety data sheet versions and distribution dates. Track which customers received which versions to ensure that updated information reaches all relevant parties.

Compliance Monitoring

Regular internal audits help identify compliance gaps before authorities do. Review your registration status, tonnage calculations, and safety data sheet accuracy on a scheduled basis. Document audit findings and corrective actions.

Track regulatory developments that may affect your substances. New restrictions, authorisation decisions, or classification changes can require rapid compliance updates.

Common Failure Patterns in REACH Compliance

Incomplete Substance Identification

One of the most common failures is submitting a dossier with incomplete or ambiguous substance identity information. Authorities cannot assess hazards or risks if they do not know exactly what substance is being registered. This failure leads to completeness check rejections and delays.

Prevent this by investing time in substance characterisation before starting the dossier. Use validated analytical methods to confirm composition and document all constituents and impurities.

Underestimating Tonnage

Companies sometimes underestimate annual tonnage, either through poor tracking or misunderstanding what counts toward the threshold. Underestimation leads to insufficient data requirements and potential non-compliance if actual tonnage exceeds the registered band.

Implement robust tonnage tracking systems and review calculations at least annually. When in doubt, register at the higher tonnage band to avoid compliance gaps.

Missing Chemical Safety Report Obligations

The chemical safety report requirement at 10 tonnes per year is frequently overlooked. Companies that register substances at lower tonnage bands may not realize that crossing the 10 tonne threshold triggers this substantial additional obligation.

Monitor tonnage against the 10 tonne threshold specifically. If you anticipate crossing this level, begin preparing the chemical safety report well in advance of the tonnage increase.

Poor Supply Chain Communication

Downstream users cannot comply with risk management measures they never receive. Failure to communicate exposure scenarios or updated safety data sheets creates compliance failures throughout the supply chain.

Establish clear procedures for safety data sheet updates and distribution. Verify that downstream users acknowledge receipt of critical safety information.

Delayed Dossier Updates

Registrations must be updated when significant new information becomes available. Companies that delay updates risk non-compliance and may face enforcement action if authorities discover the omission.

Set up a system for monitoring new data, classification changes, and tonnage variations. Submit updates promptly when triggers occur.

Welfare and Safety Context

Animal Testing Considerations

REACH aims to minimise animal testing while ensuring adequate safety data. The regulation requires that existing data be shared and that new testing only occur when necessary. Registrants must use non-animal methods where available and scientifically valid.

Companies preparing registration dossiers should first search for existing studies and consider joining substance information exchange forums to share data. This approach reduces duplication and limits animal testing.

Worker Safety in Laboratories

Laboratory staff conducting REACH studies must follow established safety protocols. This includes using appropriate personal protective equipment, following standard operating procedures, and maintaining chemical hygiene plans.

The National Institutes of Health training resources describe the importance of structured training and mentoring for laboratory personnel. Proper training reduces accidents and ensures reliable study results.

Public Health Protection

The ultimate purpose of REACH is protecting human health and the environment. Registration data supports classification and labelling that informs workers, consumers, and emergency responders about chemical hazards.

Compliance with REACH contributes to safer workplaces, safer consumer products, and reduced environmental contamination. This public health context explains why regulatory oversight is rigorous and why compliance failures carry significant consequences.

Limitations and Professional Escalation Criteria

When to Seek Expert Advice

REACH compliance involves complex scientific and legal judgments. Seek professional advice when you encounter ambiguous regulatory text, when study results are difficult to interpret, or when your organization faces enforcement action.

Regulatory affairs consultants and legal counsel with chemical regulatory expertise can provide guidance on difficult cases. Their advice is particularly valuable for novel substances, complex supply chains, or substances with unusual hazard profiles.

Escalation for Data Gaps

If required data cannot be generated due to technical limitations or ethical concerns, escalate the issue to regulatory authorities. The European Chemicals Agency provides procedures for requesting adaptations to standard information requirements.

Document all attempts to obtain data and the reasons why standard testing is not feasible. This documentation supports your adaptation request and demonstrates good faith compliance efforts.

Escalation for Enforcement Actions

If your organization receives a notice of non-compliance or faces enforcement action, escalate immediately to senior management and legal counsel. Respond to authority requests within specified deadlines and provide complete information.

Cooperate fully with authorities during inspections and investigations. Attempting to conceal compliance failures typically worsens outcomes.

Escalation for Safety Concerns

If you identify a serious safety concern with a substance, escalate the issue through your organization's safety reporting channels. This may include notifying authorities if the concern meets reporting criteria.

Document the concern, your assessment, and the actions taken. This record protects your organization and supports responsible chemical management.

Decision Framework for Choosing Between Joint Submission and Opt-Out

A newcomer to REACH compliance faces an early structural decision that shapes the entire registration process: whether to submit a joint dossier with other registrants of the same substance or to opt out and submit a standalone registration. This decision affects cost, data access, timeline, and legal exposure. The framework below gives you a practical method for making this choice with your specific circumstances in mind.

Understanding the Joint Submission Default

REACH requires manufacturers and importers of the same substance to submit registration information jointly. This mandate exists to reduce animal testing, share costs fairly, and prevent duplicate studies. The joint submission consists of two parts. The lead registrant submits the main dossier containing the full study summaries and robust study summaries for all required endpoints. Each member registrant submits their own member dossier containing substance identity, classification and labelling, and study summaries for their specific tonnage band.

The lead registrant manages the substance information exchange forum, which is the platform where registrants share data and agree on classification and labelling. The lead registrant also coordinates the preparation of the chemical safety report for the joint submission. Other registrants rely on the lead registrant's work for the shared data elements.

Criteria for Staying in the Joint Submission

Most registrants should remain in the joint submission because it spreads the cost of expensive studies across multiple companies. The cost of a full testing program for a substance at the highest tonnage band can be substantial, and sharing that cost among several registrants makes compliance financially feasible for smaller companies.

Staying in the joint submission also reduces your administrative burden. The lead registrant handles the technical dossier preparation for shared endpoints, and you submit a member dossier that references the lead dossier. This arrangement is appropriate when you agree with the lead registrant's approach to substance identification, classification, and testing strategy.

Criteria for Opting Out

REACH allows you to opt out of the joint submission under specific conditions. You may opt out when you can demonstrate that joint submission would be disproportionately costly for you, when you disagree with the lead registrant on data selection, or when you believe the joint submission would lead to a breach of confidential business information.

Opting out requires you to submit a full standalone registration dossier. This means you must have access to all required study data, either through your own testing program or through purchasing data access rights from the joint submission. You must also prepare your own chemical safety report if your tonnage requires one.

The opt-out option is rarely the right choice for a newcomer. It makes sense only when you have a compelling reason such as a fundamentally different substance composition, a dispute over data quality, or a need to protect highly sensitive process information that cannot be shared even through the data-sharing mechanisms.

Practical Decision Steps

Follow these steps when deciding whether to participate in the joint submission or opt out.

First, identify all other registrants of your substance. The European Chemicals Agency publishes a list of pre-registered substances, and substance information exchange forums are established for each substance. Contact the lead registrant or the facilitator to understand the current status of the joint submission.

Second, review the cost-sharing agreement. This agreement determines how study costs are divided among registrants. The agreement should be fair and transparent. If the proposed cost share is disproportionate to your tonnage or market share, raise the issue before agreeing to participate.

Third, assess the lead registrant's competence and responsiveness. The lead registrant must have the technical expertise to prepare a compliant dossier and the willingness to communicate with member registrants. A lead registrant who misses deadlines or provides poor data summaries creates risk for every member of the joint submission.

Fourth, evaluate the substance identity agreement. All registrants must agree on the substance composition and the analytical methods used to characterise it. If your substance has a different composition from the joint submission's substance identity profile, you may need to opt out or negotiate a separate substance identity.

Fifth, document your decision. Record the reasons for staying in the joint submission or opting out, the cost-sharing terms, and the communication history with the lead registrant. This documentation supports your compliance position if questions arise later.

Records and Measurements for the Decision

Maintain a decision log that captures the date of your decision, the options considered, the criteria applied, and the final outcome. This log should include the cost-sharing agreement, the substance identity profile, and correspondence with the lead registrant.

Track the timeline of the joint submission. Note when the lead registrant submits the joint dossier and when you submit your member dossier. Record any requests for additional information from the European Chemicals Agency and how those requests were addressed.

Monitor your tonnage against the joint submission's tonnage band. If your tonnage increases beyond the band covered by the joint submission, you may need to update your member dossier with additional data. This update obligation applies regardless of whether you are in the joint submission or opted out.

Common Failure Patterns in the Decision

The most common failure is joining a joint submission without reviewing the cost-sharing agreement carefully. Registrants who sign unfavorable agreements face unexpected costs when additional studies are required. Review the agreement with attention to how new data requirements are funded and how disputes are resolved.

Another failure is assuming the lead registrant will handle everything. The lead registrant manages the shared data, but you remain responsible for your member dossier, your tonnage declarations, and your compliance with risk management measures. Treat the joint submission as a collaboration, not a delegation.

A third failure is opting out without securing data access. If you opt out and cannot obtain the study data you need, your standalone dossier will be incomplete and your registration will fail the completeness check. Confirm data access before you commit to the opt-out path.

Escalation Criteria for the Decision

Escalate to senior management or legal counsel when the cost-sharing agreement imposes costs that threaten your business viability, when the lead registrant refuses to share data that you are entitled to access, or when a dispute over substance identity cannot be resolved through negotiation.

Escalate to the European Chemicals Agency when you believe the joint submission is not functioning as required by REACH. The agency can intervene in disputes over data sharing and cost sharing. Document your attempts to resolve the issue before escalating to the agency.

Welfare and Safety Context for the Decision

The joint submission requirement directly supports the animal welfare objectives of REACH. By sharing existing studies and avoiding duplicate testing, registrants reduce the number of animals used in toxicity testing. Your decision to participate in the joint submission contributes to this welfare outcome.

When you opt out, you must ensure that your standalone testing program does not duplicate studies already available through the joint submission. REACH requires you to search for existing data and use it where possible. Opting out does not exempt you from the obligation to avoid unnecessary animal testing.

The U.S. Department of Labor's O*NET OnLine database describes compliance-related occupations as involving detailed review of documents and coordination with multiple parties. These task descriptions apply directly to the joint submission decision, which requires careful document review and sustained coordination with other registrants.

Frequently Asked Questions

What is the difference between registration and authorisation under REACH?

Registration is a general obligation for all substances manufactured or imported above one tonne per year. Authorisation applies only to substances of very high concern listed in Annex XIV. Registration requires submitting a dossier with hazard and risk information, while authorisation requires applying for permission to use a specific substance for specific purposes.

Do US companies need to comply with REACH?

US companies are not directly subject to REACH because the regulation applies within the EU. However, US manufacturers exporting to the EU must ensure their EU-based importer registers the substance. Alternatively, the US company can appoint an only representative established in the EU to handle registration obligations.

What is an only representative under REACH?

An only representative is a legal entity established in the EU that is appointed by a non-EU manufacturer to fulfill registration and other obligations. The only representative must have sufficient background in handling substances and the associated information. Appointing an only representative allows the non-EU manufacturer to register directly instead of relying on each importer.

How long does the REACH registration process take?

The timeline varies based on substance complexity, data availability, and tonnage band. Simple substances with existing data may be registered within months. Substances requiring new studies can take several years because testing programs must be designed, conducted, and interpreted. Start the process early to avoid market access delays.

What happens if a substance is not registered under REACH?

Substances that should be registered but are not cannot be legally manufactured in or imported into the EU. This is known as the no data, no market principle. Companies placing unregistered substances on the EU market face enforcement action, including fines and product seizures.

What is a chemical safety report?

A chemical safety report documents the hazards of a substance and the risks associated with its identified uses. It includes hazard assessment, exposure assessment, and risk characterisation. The report is required for substances registered at 10 tonnes or more per year and must cover the full life cycle of the substance.

How does REACH address animal testing?

REACH requires registrants to share existing data and avoid unnecessary animal testing. Registrants must first search for available studies and may join substance information exchange forums to share data. Non-animal testing methods must be used where they are scientifically valid and provide adequate information.

What careers are available in chemical regulatory affairs?

Chemical regulatory affairs offers roles including regulatory affairs scientist, regulatory affairs specialist, toxicologist, risk assessor, and data manager. These roles require scientific training and knowledge of regulatory requirements. Career development resources are available through professional organizations and federal agencies that describe pathways in scientific and regulatory fields.

Using the Evidence

Related Articles

• Cosmetics Regulatory Affairs Jobs: What You Need to Know
• Regulatory Affairs in Cosmetics: A Specialized Career Path
• Biotech Regulatory Affairs Jobs: Roles, Skills, and Career Path
• Regulatory Science Careers: Navigating Compliance and Policy Roles
• Regulatory Affairs Careers in Cosmetics: Skills, Pathways, and Job Outlook

References and Further Reading

• Occupational Outlook Handbook. U.S. Bureau of Labor Statistics.
• O*NET OnLine. U.S. Department of Labor.
• Office of Intramural Training and Education. National Institutes of Health.
• Careers at NSF. U.S. National Science Foundation.
• Career Services. American Society for Microbiology.
• AAVMC Career Resources. Association of American Veterinary Medical Colleges.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.